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Human height is a highly heritable trait, withgenetic factors explaining up to 90% of pheno-
typic variation. Vitamin D levels are known to
influence several physiological processes, including
skeletal growth. The vitamin D receptor (VDR) gene
has been reported as contributing to variation in
height. A meta-analysis of 13607 adult individuals
found a small but significant association with the
rs1544410 (BsmI) polymorphism. In contrast, the
meta-analysis found no effect in a sample of 550
children. Two recent studies reported variants with
large effect on height elsewhere in VDR (rs10735810
[FokI] and rs7139166 [-1521] polymorphisms). We
genotyped large Caucasian samples from Australia
(N = 3906) and the Netherlands (N = 1689) for poly-
morphisms in VDR. The Australian samples were
twin families with height measures from 3 time
points throughout adolescence. The Dutch samples
were adult twins. We use the available family data to
perform both within and between family tests of
association. We found no significant associations for
any of the genotyped variants after multiple testing
correction. The (non-significant) effect of rs1544410
in the Australian adolescent cohort was in the same
direction and of similar magnitude (additive effect
0.3cm) to the effect observed in the published adult
meta-analysis. An effect of this size explains ~0.1%
of the phenotypic variance in height — this implies
that many, probably hundreds, of such variants are
responsible for the observed genetic variation. Our
results did not support any role for two other regions
(rs10735810, rs7139166) of VDR in explaining varia-
tion in height.
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Height is one of the most highly heritable human traits,
with heritability estimates up to 90%, particularly
when measurement error is minimized (Macgregor et
al., 2006; Silventoinen et al., 2003). Height has long
been the subject of genetic studies, beginning with
Galton in the 19th century (Galton, 1886). As a result
of improved environment (primarily nutrition), mean
height has increased over the second half of the 20th
century (Vogel & Motulsky, 1997). Despite the
increases in mean height, the mean difference between
European countries has remained stable and trait vari-
ance and heritability estimates are broadly similar
across countries (Silventoinen et al., 2003). In recent
years the role of short stature as a risk factor for car-
diovascular disease has been hotly debated, with a
number of reports of an inverse correlation between
stature and disease risk (Hebert et al., 1993; Kannam
et al., 1994).
The effects of the vitamin D receptor (VDR) gene
on height and on various bone measurements has been
the subject of many studies. Linkage studies have indi-
cated that several chromosomes are likely to influence
height (Hirschhorn et al., 2001; Perola et al., 2001,
2007). The linkage peaks include chromosome 12q,
the location of the VDR gene, with one study finding
genome wide significant linkage (Hirschhorn et al.,
2001) and others finding weaker (suggestive) evidence
(Dempfle et al., 2006; Hirschhorn et al., 2001; Perola
et al., 2001). In some cases, linkage was found by
examining the extreme low end of the height range
(Dempfle et al., 2006).
Several studies have examined the VDR gene for
association with height. The most widely typed poly-
morphism examined, rs1544410 (BsmI), was the focus
of a meta analysis (Fang et al., 2007) that concluded
that this variant (or one in high linkage disequilibrium
with it) had a significant effect on height (additive
effect of each copy of B allele = 0.3cm). This effect
was only significant in the adult samples examined,
with child samples indicating a (nonsignificant) effect
in the opposite direction to that seen in the adult
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samples. Since the collation of the data for the meta-
analysis, further studies have been published on the
effects of rs1544410 (BsmI) on height. A number
(d’Alesio et al., 2005; Dempfle et al., 2006; Handoko
et al., 2006) reported no association between
rs1544410 (BsmI) and height. Conversely, another
study (Xiong et al., 2005) found evidence for associa-
tion and for linkage (single marker p values in range
.01 to .05). Some studies have examined regions of the
VDR gene which are in linkage equilibrium with the
region containing rs1544410 (BsmI). One (Dempfle et
al., 2006) found weak (p=0.04) evidence for associa-
tion with rs10735810 (FokI), whilst another did not
(p > .05, Terpstra et al. (2006)). Another (d’Alesio et
al., 2005), found similarly weak (p = .05) evidence for
association with a different region rs7139166 (–1521).
All these previous results are summarized in Table 1.
Here, we examine the relationship between height
and the VDR polymorphisms in a large sample of
Australian and Dutch twin families. The goal is to
compare and add to the previous results, using family
based tests of association, which have not been uti-
lized in many of the earlier studies.
Material and Methods
Phenotypic Data
Australian Caucasian Sample
The Australian data used in this paper were derived
from a study of adolescent twins recruited from the
Australian Twin Registry. The zygosity of twin pairs
was initially determined by twins’ responses to stan-
dard items about physical similarity and the degree to
which others confused them with one another. Many
of the twins were subsequently included in studies in
which they were typed for large numbers of genetic
markers. As a result we expect misclassifications to be
very rare in this sample (Cornes et al., 2005).
The data consisted of 1077 families. Each family
had one twin pair, with 45% of families also having
one or more additional siblings. 77% of parents, 83%
of twins and 88% of additional siblings of individuals
were genotyped (82% overall). The sample included
both monozygotic and dizygotic twins. Twins and
their siblings were measured for height at up to three
age points; 12, 14 and 16 years. Height measurements
were performed by an experienced research nurse.
Dutch Caucasian Sample
The Dutch data on body height were obtained from a
longitudinal survey study on health, lifestyle and per-
sonality by the Netherlands Twin Register (NTR, for a
detailed description see Boomsma et al. (2006)).
Surveys were sent out every 2 to 3 years to twins and
their family members. The twins were included all
surveys (1991, 1993, 1995, 1997, 2000, 2002 and
2004); parents in 1991, 1993, 2000, 2002, 2004; sib-
lings of twins were invited from 1995 onwards and
spouses of twins were included from 2000 onwards.
In each survey, individuals were asked to report on
their body height in cm. In addition, measured height
was available from several subsamples of the NTR
which took part in laboratory studies of cardiovascu-
lar risk factors, brain function and cognition. All
available measures on body height from age 18 years
onwards were combined into one adult body height,
with preference given to measured height (available
for 15% of the sample). When measured height was
unavailable, and self-reported height was present for
multiple surveys, the average self-reported height was
used. Differences in height across the questionnaires
were checked and height data were discarded when
there was no consistency across questionnaires and
differences were larger than 5 cm (N = 35). The corre-
spondence between measured height and average
height based on self-reports is 0.93 (Silventoinen et al.,
2003). As during the last century the average stature
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Table 1
Previously Reported Results
Authors Age Sample size rs1544410 rs731236 rs10735810 rs7139166
(BsmI) (TaqI) (FokI) (-1521)
Xiong et al. Adult 1873 0.05 0.04
(406)
D’Alesio et al. Teenage 185 0.26 0.05* 0.05*
Terpstra et al. Teenage 255 NS
Handoko et al. Adult 368 NS NS NS
Dempfle et al. Child 184 0.7 1 0.04
(91)
Fang et al. (Meta anal.) Adult/child 14157 0.006
Fang et al. (Meta anal.) Child only subset 550 0.95
Note: Alternative marker names are in brackets after rs names. Unless otherwise stated results are p values for single SNP test under an additive model (trend test). Blank cells
indicate that marker was not typed in that study. NS denotes case where association was reported to be nonsignificant (p > .05) but insufficient details were given to give an
exact p value. * denotes cases where result was for haplotype based test. For family-based samples, the total number of individuals is given, followed by the number of fami-
lies in brackets; for population-based samples the sample size column contains a single number (i.e., the total number of individuals). P values for family based analyses are
for the within family test.
of the Dutch population has increased rapidly with
every generation (Fredriks et al., 2000), we used birth
year as a covariate. Stature and genotypic information
were available for 1687 individuals from 493 families.
For 485 families, data on 487 parents were also avail-
able. The sample included both monozygotic and
dizygotic twins. The average age of the Dutch popula-
tion at measurement(s) was 39 years.
Genotype Data
SNPs were selected in the VDR gene based on previous
studies (Table 2). We also typed rs4516035 (= –1012
from d’Alesio et al. [2005]) in the Australian sample;
this was in very high r2 (r2 = 0.95) with rs7139166 and
hence association results are very similar (data not
shown). Assays were designed using the Sequenom
MassARRAY Assay Design (version 3.1) software
(Sequenom Inc., San Diego, CA).
For the Australian samples, forward and reverse
PCR primers and primer extension probes were pur-
chased from Bioneer Corporation (Daejeon, Korea).
Genotyping was carried out in standard 384-well
plates with 12.5 ng genomic DNA used per sample.
We used a modified Sequenom MassARRAY protocol
where half reaction volumes were used in each of the
PCR, SAP and iPLEX stages giving a total reaction
volume of 5.5 µL. The iPLEX reaction products were
desalted by diluting samples with 18 µL of water and
3 µL SpectroCLEAN resin (Sequenom) and then
spotted on a SpectroChip (Sequenom), processed and
analyzed on a Compact matrix assisted laser desorp-
tion/ionization time-of-flight mass spectrometry
(MALDI-TOF) Mass Spectrometer by MassARRAY
Workstation software (version 3.3; Sequenom). Allele
calls for each 384-well plate were reviewed using the
cluster tool in the MassARRAY TyperAnalyzer 3.4
software (Sequenom) to evaluate assay quality. Call
rates of ≥98% were achieved for all SNPs. Discordant
genotypes between MZ twins and mendelian errors
were identified using PEDSTATS (Wigginton and
Abecasis, 2005) and made up 0.07% of the data.
For the Dutch samples, DNA was extracted from
whole blood or buccal swab (Miller et al., 1988;
Meulenbelt et al., 1995; Min et al., 2006). To assay
these polymorphisms, we used a modified Mass ARRAY
protocol where the polymerase chain reaction (PCR)
cycling protocol was performed as a ‘touchdown’ pro-
tocol (i.e., 15 min at 95 ± C, followed by 4 cycles of 20
s at 95 ± C, 30 s at 65 ± C and 1 min at 72 ± C, then
followed by 4 cycles of 20 s at 95 ± C, 30 s at 58 ± C
and 1 min at 72 ± C, and subsequently followed by
38 cycles of 20 s at 95 ± C, 30 s at 53 ± C and1 min
at 72 ± C. Final extension was carried out at 72 ± C
for 3 min, and the sample was cooled to 15 ± C).
Reaction products were desalted, processed and ana-
lyzed on an Autoflex (Bruker, Wormer, Netherlands)
MALDI-TOF Mass Spectrometer and genotypes were
assigned real-time using MassARRAY Typer3.4 soft-
ware (Sequenom). As quality controls, 5 to 10% of the
Dutch samples were genotyped in duplicate. No incon-
sistencies were observed. Positive and negative controls
uniquely distributed in each 384 wells plate were also
consistent. Cluster plots were made of the signals from
the low and the high mass allele. Two independent
researchers carried out scoring. Disagreements or
vaguely positioned dots produced by Typer Analyzer
3.4 (Sequenom) in addition to all wells that had 50%
or more failed SNPs were excluded from analysis.
Statistical Methods
We estimated allele frequencies for each SNP using a
maximum likelihood procedure in SOLAR (http://
www.sfbr.org/solar). Markers were tested for devia-
tion from Hardy-Weinberg equilibrium using pedstats
(www.sph.umich.edu/csg/abecasis/PedStats). Tests for
association were performed using QTDT (www.sph.
umich.edu/csg/abecasis/QTDT/). In both samples sex,
age, age squared and a sex–age interaction were fitted
as covariates (in the Australian data there was still
some age variation between individuals within the 12,
14 and 16 age groups). Tests were done for both
within family association (which is unaffected by any
population stratification) and total association (which
can be affected by population stratification). The
within family test uses information from transmissions
from parents to offspring (typically the deviation of
coded offspring genotypes from the expected coded
genotypes given the parental genotypes) and relates
this information to the observed phenotypes in a vari-
ance components framework. The total association
test uses the information from transmissions but also
uses between family information (in the simplest case
where parents are genotyped, this means the coded
parental genotypes are used in the model in addition
to the coded offspring genotype deviations from the
coded parental genotypes, see Abecasis et al. (2000)
for full details). In each case association was modeled
using variance terms for linkage; this maximizes
power and maintains type I error at the expected level
(Abecasis et al., 2000).
Results
All markers showed no deviations from Hardy-
Weinberg equilibrium (p > .05). The allele frequencies
of each SNP are given in Table 2. These frequencies
are similar to those observed in other Caucasian popu-
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Table 2
Allele Frequency Estimates
Australia Netherlands
rs7139166 (-1521) 0.43 (G/C) 0.43 (G/C)
rs10735810 (FokI) not typed 0.35 (T/C)
rs1544410 (BsmI) 0.41 (G/A) (b/B) 0.43 (G/A) (b/B)
rs731236 (TaqI) 0.41 (T/C) (T/t) 0.41 (T/C) (T/t)
Note: Markers are in order from 5’ end of gene. Alleles are coded in brackets after the
frequencies.
lations (Fang et al., 2007). As expected, rs1544410
(BsmI) was in high linkage disequilibrium (LD) with
rs731236 (TaqI); the observed LD (Australian and
Dutch; r2 > 0.9) is stronger than reported elsewhere
(Xiong et al., 2005).
Association test results are given in Table 3. There is
little evidence for association to any of the genotyped
variants for the Australian sample (smallest p value .08
without correction for multiple testing). For the Dutch
data there is slight evidence for within family associa-
tion for marker rs10735810 (FokI), p =.02. However,
no evidence for association was found using the total
(i.e., between + within) association tests. The within-
between discrepancy is also observed in the QTDT test
for population stratification (p = .03 for rs10735810).
The other three markers, rs7139166 (–1521), rs731236
(TaqI) and rs1544410 (BsmI) showed no evidence for
association. After correction for multiple testing, all
total and within association results are not significant
(p >.05). The nominally significant population stratifi-
cation test result (p = .03 before correction for
multiple testing) for rs10735810 is likely to be a mul-
tiple testing artefact.
Discussion
In two previous reports (d’Alesio et al., 2005; Dempfle
et al., 2006), the rs7139166 (–1521) and rs10735810
(FokI) polymorphisms were reported to significantly
influence variation in height. In two large samples
from Australia and the Netherlands, we found little
support for the role of the rs7139166 (–1521) poly-
morphism in determining height. For rs10735810
(FokI) the Dutch data showed some evidence of within
family association, but no between family association.
Here, in addition to the possibility of this being a
chance finding due to multiple testing, population sub-
structure, generational height differences, as well as an
increased sample size in the between family analysis
could have played a role. After correction for multiple
testing, the rs10735810 (FokI) result is nonsignificant.
The samples typed are more than an order of magni-
tude larger than previous reports and would hence
have excellent power to replicate the previously
reported (large) effect sizes.
The rs1544410 (BsmI) polymorphism (and the cor-
related rs731236 [TaqI] polymorphism) was found to
have a nonsignificant effect on height in both our
samples. In previous studies, the B allele (as defined in
Fang et al. (2007)) was associated with increased
height. In a large meta-analysis which considered only
population based samples (Fang et al., 2007), the B
allele had an additive effect of +0.3cm on height. In
the Australian samples here, the nonsignificant effect
of the B allele was of similar magnitude to this for
both total and within association models. In the Dutch
samples the B allele additive effect was larger for the
total model (+0.6cm) and in the opposite direction for
the within model (–0.2cm). Even if the Australian and
Dutch samples were analyzed together, the effect of the
B allele would still not be significant (p > .05). The
fact that our large sample was unable to generate a
significant result for this VDR variant raises questions
about the overall importance of this locus to variation
in height. In Caucasian populations, the rs1544410
(BsmI) variant typically has minor allele frequency
close to the frequency observed here, 0.41. This fre-
quency and effect size (additive effect ~0.3cm) implies
that the rs1544410 (BsmI) variant explains ~0.1% of
the variance in height. In Asian populations the fre-
quency is ~7%, implying the rs1544410 (BsmI) variant
explains ~0.03% of the variance. The effect size in
terms of proportion of variance is one of the primary
determinants of the power of genetic association
studies of quantitative traits. The sample size required
to detect, with 80% power, a QTL explaining 0.1% of
the variance at the alpha = 5% level is 7845 (assuming
a population based sample and assuming complete
LD between variant and marker). For a genome wide
association study (alpha = 0.0000001), 38030 samples
are required.
In the light of the likely small effect size at
rs1544410 (BsmI), the failure of most of the studies
performed since the meta-analysis to find any signifi-
cant results is not surprising (d’Alesio et al., 2005;
Dempfle et al., 2006; Handoko et al., 2006) find no
association, Xiong et al.(2005) find nominally signifi-
cant single SNP p values). One study (Xiong et al.,
2005) increased their evidence for association by per-
forming haplotype based analysis but in our data the
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Table 3
Association Results
Australia Netherlands
Within family Between family Within family Between family
Age 12 14 16 12 14 16 Adult Adult 
rs7139166 (-1521) 0.74 0.47 0.47 0.64 1 0.5 0.62 0.99
rs10735810 (FokI) NA NA NA NA NA NA 0.02 0.26
rs1544410 (BsmI) 0.41 0.08 0.28 0.2 0.14 0.26 0.91 0.38
rs731236 (TaqI) 0.51 0.15 0.38 0.19 0.17 0.3 0.7 0.48
Note: Results are p values
haplotype based results are similar to the (non-signifi-
cant) single SNP results. The similarity between single
SNP and haplotype results was because our sample
showed high LD between rs1544410 (BsmI) and
rs731236 (TaqI). The observed r2 here was higher than
reported by Xiong et al. (2005) and is interesting
because it impacts upon the haplotype frequencies.
Xiong et al. (2005) report that the 4 haplotype fre-
quencies for rs731236, rs1544410 are 0.05, 0.37,
0.53, 0.05. In contrast, due to the high LD that we
observe, there are only 2 haplotypes at appreciable
frequency in the Australian or Dutch data (combined
haplotype frequencies of 2 most frequent haplotypes >
0.98). This of course means that the 2 locus haplotype
based association results are rather similar to the
single locus results for either rs1544410 (BsmI) or
rs731236 (TaqI) (data not shown). This result con-
trasts with the results in Xiong et al. (2005), where
the most significant results are for haplotypes (in par-
ticular for haplotypes we only find at a very low
frequencies in our data).
SNPs within VDR have been examined in two
publicly available genome-wide association studies.
Association results from British 1958 Birth Cohort
(1958BC) have been made available (http://www.
b58cgene.sgul.ac.uk/) and the rs10735810 (FokI) and
rs1544410 (BsmI) SNPs appear in their set of ~1500
(unrelated) genotyped individuals. Neither show any
evidence of association (p > .5) — this is likely to also
be true for rs731236 (TaqI) because both the
Australian and Dutch samples found substantial
linkage disequilibrium between rs1544410 and
rs731236. rs7139166 (–1521) is not typed but it has
r2 = 1 with rs4516035 which is genotyped in 1958BC
— there is nominal evidence for an association with
height for this SNP in 1958BC (p = .03). In total 43
SNPs are typed in the 1958BC; aside from rs4516035
(and the adjacent SNP), there are no SNPs which
show evidence for association (p > .10). Association
results from the Framingham Heart Study (FHS) data
(Cupples et al., 2007; http://www.ncbi.nlm.nih.gov/
projects/gap/cgi-bin/analysis.cgi?id=pha000136) are
available (1380 genotyped individuals in families) but
presently only 4 SNPs in the VDR gene are available
that pass quality control. None of the 4 FHS typed
SNPs are the same as those typed here although one of
the SNPs typed in the FHS, rs3890734, is in high
linkage disequilibrium (r2 = 0.66) with rs7139166.
None of the 4 SNPs show evidence for association in
the FHS (all p > .30).
Very recently, three height genome wide association
studies have been published (Gudbjartsson et al.,
2008; Lettre et al., 2008; Weedon et al., 2008). In each
of these studies, the authors report the top 20-60 SNPs
identified from a genome-wide scan followed by indi-
vidual genotyping. None of the associated SNPs are
near VDR (all chromosome 12 SNPs >20 megabases
away). The closest gene with associated SNPs was the
previously reported HMGA2 gene (Sanna et al., 2008;
Weedon et al., 2007), ~21 megabases from VDR.
We have not examined as many SNPs as in the
study by Fang et al. (2007). In particular, since the 3
groups of SNPs (rs7139166, rs10735810 and
rs1544410/ rs731236) are in linkage equilibrium, we
have not reported the results of haplotype analysis. In
Fang et al. (2007), a combination of variants that
increased body height was assembled into a haplotype
genotype, which increased height with an additive
effect of 0.7cm (reported as difference between
homozygotes = 1.4cm in the Rotterdam Study).
Examining the composition of the particular combina-
tion, it is clear that much of this effect comes from
variation in the rs1544410 (BsmI) region (Block 5 Hap
2 in Fang et al. [2007], additive effect in Rotterdam
Study = 0.45cm). Although we have not typed all the
relevant SNPs to enable us to replicate the haplotype
genotype result in Fang et al. (2007), since we find
little evidence for association near rs1544410 (BsmI),
our data suggest the haplotype genotype will not have
a large effect upon height.
The effect of rs1544410 (BsmI) variation in deter-
mining height at different ages is of interest. The
opposite effect direction to that seen in adults was
seen in a small (n = 550) meta-analysis of younger
individuals, although in this case the effect of
rs1544410 (BsmI) on height was nonsignificant (Fang
et al., 2007). For the Australian adolescent sample, the
(nonsignificant) effect of rs1544410 (BsmI) was in the
same direction as in found in adults. Overall, it
appears that the effects of rs1544410 (BsmI) on height
are likely to be small, in both adult and child groups.
In summary, our results provide no evidence to
support the claimed large effect sizes of the
rs10735810 (FokI) and rs7139166 (–1521) polymor-
phisms in VDR for height (d’Alesio et al., 2005;
Dempfle et al., 2006). The effect of the previously
reported rs1544410 (BsmI) polymorphism on height is
also likely to be small. More generally, very recent
studies (Gudbjartsson et al., 2008; Lettre et al., 2008;
Visscher et al., 2007; Weedon et al., 2008) underline
the fact that height is a polygenic trait, whose varia-
tion is underpinned by a great many different loci of
small effect.
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